A5107481535- Thyroid Cancer Diagnosis and Treatment
- Thyroid and Parathyroid Surgery
- Head and Neck Anomalies
- BRCA gene mutations in cancer
- Thyroid Disorders and Treatments
- Cancer Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Global Cancer Incidence and Screening
- Biomedical and Engineering Education
- Radiopharmaceutical Chemistry and Applications
- Mobile Health and mHealth Applications
- Salivary Gland Tumors Diagnosis and Treatment
- Radiation Dose and Imaging
- Patient-Provider Communication in Healthcare
- Telemedicine and Telehealth Implementation
- Medical and Biological Sciences
- Cervical Cancer and HPV Research
- Circadian rhythm and melatonin
- Ovarian cancer diagnosis and treatment
- Pituitary Gland Disorders and Treatments
- Ovarian function and disorders
- Hypothalamic control of reproductive hormones
Mayo Clinic in Florida
1982-2024
Mayo Clinic
2006-2023
Mayo Clinic in Arizona
2014-2023
Sahlgrenska University Hospital
2018
Orange (Belgium)
2012
The objective of this study was to evaluate the technique, efficacy, and side effects percutaneous ethanol injection in patients with limited cervical nodal metastases from papillary thyroid carcinoma.Fourteen who had undergone thyroidectomy for carcinoma presented (one five involved nodes) neck between May 1993 April 2000. All received previous iodine-131 ablative therapy a mean total dose per patient 7,548 MBq. Ten either were considered poor surgical candidates or preferred not have...
An ongoing epidemic of thyroid carcinoma (TC) has affected Americans since 1975. Understanding the contribution subclinical disease and mechanism such detection may help to alter course this epidemic.We used Rochester Epidemiology Project resources examine incidence TC cases, specific mortality, method diagnosis during 1935 through 2012. During 2000-2012, we also extracted clinically occult tumors.The age-adjusted (AAI) for increased from 7.1 [95% confidence interval (CI) 5.5-8.8] per...
Medullary thyroid cancer (MTC) can be associated with significant morbidity and mortality in advanced cases. Hence, we aimed to identify factors at the time of MTC surgery that predict overall survival (OS), disease-specific (DSS), locoregional recurrence/persistence (LR), distant metastases (DM).
Thyroid ultrasound screening has been involved in routine physical examination at hospitals.However, due to the uneven development of medical resources, diagnostic accuracy for thyroid nodules varies greatly.The aim this study was explore a novel artificial intelligence-assisted system improve diagnosis efficiency and nodules.The developed based on computer deep learning, training multi-frame dynamic image recognition techniques.In order validate system, 500 pathologically confirmed were...
ObjectiveTo determine whether radioiodine remnant ablation (RRA) reduces cause-specific mortality (CSM) or tumor recurrence (TR) rate after bilateral lobar resection (BLR).Patients and MethodsThere were 2952 low-risk adult papillary thyroid cancer (LRAPTC) patients (with MACIS scores <6) who underwent potentially curative BLR during 1955-2014. During 1955-1974, 1975-1994, 1995-2014, RRA was administered in 3%, 49%, 28%. Statistical analyses performed using SAS software.ResultsDuring the...
To determine whether radioiodine remnant ablation (RRA) reduces cause-specific mortality (CSM) or tumor recurrence rates (TRR) after potentially curative bilateral thyroidectomy (BT) in low-risk adult papillary thyroid carcinoma (APTC) patients, we compared postoperative outcomes 1836 pTNM stage I APTC patients having BT alone with 832 BT+RRA during two consecutive 25-year periods.The THEN cohort (consecutively managed 1966-1990) comprised 809 (36% BT+RRA) and the NOW (1991-2015) 1859 (29%...
Currently acceptable management options for patients with adult papillary thyroid microcarcinoma (APTM) range from immediate surgery, either unilateral lobectomy or bilateral lobar resection, to active surveillance (AS). An alternative minimally invasive approach, originally employed eliminating neck nodal metastases, may be ultrasound-guided percutaneous ethanol ablation (EA). Here we present our experience of definitively treating EA 15 APTM.During 2010 through 2017, the cT1aN0M0 selected...
Abstract Objective Results of ethanol ablation (EA) for controlling neck nodal metastases (NNM) in adult patients with papillary thyroid carcinoma (APTC) beyond 6 months have rarely been reported. We now describe outcome results 71 NNM 40 node-positive stage I APTC followed 66 to 269 months. Methods All were managed bilateral thyroidectomy and radioiodine therapy ultrasound (US) &gt;48 after EA. Cumulative doses ranged from 30 550 mCi; pre-EA 27 (67%) had 36 additional surgeries....
REPLY: We appreciate Professor Bourgeois' thoughtful letter. Our perspective ( [1][1] ) was limited to making major points indict ablation in the management of thyroid carcinomas, and questions offer an opportunity expand on our thesis. agree with Bourgeois
Abstract Context Childhood papillary thyroid carcinoma (CPTC), despite bilateral thyroidectomy, nodal dissection and radioiodine remnant ablation (RRA), recurs within neck metastases (NNM) in 33% 20 postoperative years. These NNM are usually treated with reoperation or further radioiodine. Ethanol (EA) may be considered when numbers of limited. Objective We studied the long-term results EA 14 patients presenting CPTC during 1978 to 2013 having for 2000 2018. Methods Cytologic diagnoses...
Ultrasound-guided percutaneous ethanol ablation procedures for locoregional recurrences in papillary thyroid carcinoma (PTC) can be repeatedly performed over years. Skin metastases (SM) from PTC generally portend a lethal prognosis. Our patient case report demonstrates the innovative use low-risk (LRPTC) of treatment modalities designed to prevent neck re-explorations and capable eliminating both SM. In 2004, 48-year-old man presented with nodal due PTC. He underwent near-total thyroidectomy...